+ Watch NVAX
on My Watchlist
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
The fear of a significant pandemic seem, for the first time in a very long time, justified. Pandemic H1N1 seems to be a significant possibility. This small company just obtained 2 partnerships (in Spain and India) with credible companies. The Spanish gouvernment favors Novavax tech. They seem to have beaten Crucell (sad for me...).Their technology is impressive yet simple. Nasal administration is likely as one of the ways this vaccine could be administered.They have a few other vaccines in the pipeline that have a 'real shot' of eventually being approved. This is a long term play on good and scalable technology. Also a short term play on a pandemic. To me the 'hype' so far doesn't seem to be excessive (if a pandemic is really coming!) although small companies like Novavax and Sinovac have done very well with it. Vaccines are the most cost effective way of improving health. The manifacturing of influenza vaccines will eventually be replaced (ie: Novartis) and companies like Crucell and Novavax will benefit greatly.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions